Mechanistically, hyperinsulinemia elevates insulin-like growth factor-1 (IGF-1) levels, a potent mitogen that promotes cellular proliferation and inhibits apoptosis, accelerating CRC progression [18]. The gene discussed is IGF1; the disease is hyperinsulinism.